366 related articles for article (PubMed ID: 23264330)
1. Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema.
Habot-Wilner Z; Sallam A; Pacheco PA; Do HH; McCluskey P; Lightman S
Eur J Ophthalmol; 2011; 21 Suppl 6():S56-61. PubMed ID: 23264330
[TBL] [Abstract][Full Text] [Related]
2. Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children.
Sallam A; Comer RM; Chang JH; Grigg JR; Andrews R; McCluskey PJ; Lightman S
Arch Ophthalmol; 2008 Feb; 126(2):200-5. PubMed ID: 18268210
[TBL] [Abstract][Full Text] [Related]
3. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis.
Hogewind BF; Zijlstra C; Klevering BJ; Hoyng CB
Eur J Ophthalmol; 2008; 18(3):429-34. PubMed ID: 18465727
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.
Rahimi M; Shahrzad SS; Banifatemi M
Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis.
Maca SM; Abela-Formanek C; Kiss CG; Sacu SG; Benesch T; Barisani-Asenbauer T
Clin Exp Ophthalmol; 2009 May; 37(4):389-96. PubMed ID: 19594566
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.
Dong Z; Namba K; Kitaichi N; Goda C; Kitamura M; Ohno S
Jpn J Ophthalmol; 2008; 52(5):374-379. PubMed ID: 18991038
[TBL] [Abstract][Full Text] [Related]
11. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Jonas JB; Kreissig I; Kamppeter B; Degenring RF
Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy and safety of subconjunctival triamcinolone acetonide injections in treatment of uveitic macular edema].
Liu X; Wang M; Zhao C; Gao F; Zhang M
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):734-8. PubMed ID: 26693767
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
Soheilian M; Eskandari A; Ramezani A; Rabbanikhah Z; Soheilian R
Ocul Immunol Inflamm; 2013 Apr; 21(2):124-9. PubMed ID: 23697857
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema.
Choudhry S; Ghosh S
Clin Exp Ophthalmol; 2007 Nov; 35(8):713-8. PubMed ID: 17997773
[TBL] [Abstract][Full Text] [Related]
16. Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema.
Lasave AF; Schlaen A; Zeballos DG; Díaz-Llopis M; Couto C; El-Haig WM; Arevalo JF
Ocul Immunol Inflamm; 2019; 27(2):294-302. PubMed ID: 29157128
[TBL] [Abstract][Full Text] [Related]
17. Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema.
Lasave AF; Zeballos DG; El-Haig WM; Díaz-Llopis M; Salom D; Arevalo JF
Ocul Immunol Inflamm; 2009; 17(6):423-30. PubMed ID: 20001264
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative intravitreal triamcinolone acetonide injection for prevention of postoperative inflammation and complications after phacoemulsification in patients with uveitic cataract.
Ren Y; Du S; Zheng D; Shi Y; Pan L; Yan H
BMC Ophthalmol; 2021 Jun; 21(1):245. PubMed ID: 34088282
[TBL] [Abstract][Full Text] [Related]
19. [Safety and efficacy of subconjunctival triamcinolone injections in the management of uveitic macular edema: retrospective study of thirty-one cases].
Bleriot A; Couret C; Le Meur G; Lebranchu P; Weber M
J Fr Ophtalmol; 2014 Oct; 37(8):599-604. PubMed ID: 25199486
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease.
Atmaca LS; Yalçindağ FN; Ozdemir O
Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):451-6. PubMed ID: 17226025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]